MR posts
FeedPosted Jan 10th 2011 1:30PM by Brent Archer (RSS feed)
Filed under: Major Movement, Earnings Reports, Forecasts, Good news, China, Options, Technical Analysis

Mindray Medical (
MR -
option chain) shares are rising today after the Chinese medical devices company announced
preliminary 2010 results, saying it now expects fiscal-2010 revenues to come in at $703 million, up from a previous forecast of $700 million.
Analysts have forecast 2010 revenue of $703.56 million. If you think that the stock won't fall by too much in the coming months, then now could be a good time to look at a bullish hedged trade on MR.
MR opened this morning at $28.05. So far today the stock has hit a low of $28.02 and a high of $29.04. As of 12:15, MR is trading at $28.25 up $1.20 (4.4%). The chart for MR looks neutral and
S&P gives MR a neutral 3 STARS (out of 5) hold ranking.
Continue reading Mindray Medical Announces Strong Preliminary Earnings Results
Posted Aug 25th 2010 12:00PM by Eric Buscemi (RSS feed)
Filed under: Analyst Reports, Analyst Upgrades and Downgrades, Corning Inc (GLW), Family Dollar Stores (FDO), Analyst Initiations, Trina Solar ADS (TSL), Intuitive Surgical Inc (ISRG)
Analyst Upgrades
- Wells Fargo believes Intuitive Surgical (ISRG) da Vinci procedures remain under penetrated and that consensus estimates are too low. The firm upgraded shares to outperform from market perform and raised its valuation range to $340 to $360.
- Cantor Fitzgerald upgraded Westamerica (WABC) to buy from hold due to the company's FDIC-assisted acquisition of Sonoma Bank and what the firm sees as Westamerica's defensive nature. The firm set a $62 target on the stock.
- Oppenheimer upgraded Corning (GLW) to outperform from perform based on valuation and the belief that downward revisions have peaked. The firm has a $20 target on the stock.
- Quality Systems (QSII) was upgraded to outperform from market perform at JMP Securities.
- OpenTable (OPEN) and Windstream (WIN) were upgraded to buy from neutral at BofA/Merrill.
Continue reading Analyst Calls: FDO, GLW, ISRG, MDT, N, NLY, QLIK, RLD, TSL, WABC ...
Posted Aug 10th 2010 12:00PM by Eric Buscemi (RSS feed)
Filed under: Analyst Reports, Analyst Upgrades and Downgrades, Best Buy (BBY), Whole Foods Market (WFMI), Texas Instruments (TXN), Analyst Initiations, Northrop Grumman (NOC)
Analyst Upgrades
- Goldman believes EOG Resources (EOG) can regain its premium multiple given its ability to find new horizontal liquids resource plays. The firm upgraded shares to conviction buy from buy and has a $129 price target on the stock.
- Deutsche Bank upgraded Macerich (MAC) to buy from hold following the company's Q2 results and raised its target for shares to $47 from $45.
- Needham upgraded QuinStreet (QNST) to strong buy from buy, citing the strong Q4 report and valuation, and has a $20 target on the stock.
- Macy's (M) was upgraded to buy from neutral at BofA/Merrill.
- Whole Foods (WFMI) was upgraded to buy from neutral at UBS.
- Texas Instruments (TXN) was upgraded to outperform from market perform at Raymond James.
Continue reading Analyst Calls: BBY, BWA, DGI, EOG, M, MAC, MR, NOC, TXN, WFMI ...
Posted Apr 19th 2010 12:00PM by Steven Halpern (RSS feed)
Filed under: International Markets, Newsletters, Stocks to Buy, Potash Corp. of Saskatchewan (POT)
"We believe many outstanding buying opportunities are available among these undervalued foreign stocks; we screened the Zacks, Investors Business Daily, S&P and Value Line databases to find foreign companies with rapidly growing earnings," says
J. Royden Ward.
The editor of
Cabot Benjamin Graham Value Letter explains, "We believe these six companies offer excellent appreciation potential at reasonable prices: Lululemon Athletica (
LULU), Mindray Medical (
MR), Potash (
POT), Seagate Technology (
STX), Silver Wheaton (
SLW) and Telefonica SA (
TEF)."
Continue reading 'Ben Graham' Buys: Six-Pack of Foreign Value Stocks
Posted Jan 8th 2010 4:15PM by Steven Halpern (RSS feed)
Filed under: Newsletters, Stocks to Buy, Best Stocks for 2010
This post is part of a special report, Top Picks for 2010, the 27th annual survey in which TheStockAdvisors.com asks the nation's leading advisors for their single favorite stock for the new year. See all 80 stocks listed here.
"Mindray Medical International Limited (MR), a China-based medical devices firm, is our top investment idea for the coming year," says Alan Newman.
In his CrossCurrents newsletter, he notes, "The company is headquartered in Shenzhen, China, and is one of many Chinese companies now specializing in the development, manufacture and marketing of medical devices worldwide.
Continue reading Top Picks for 2010: Mindray Medical (MR)
Posted May 8th 2009 10:30AM by Steven Halpern (RSS feed)
Filed under: QUALCOMM Inc (QCOM), PetroChina Co Ltd ADR (PTR), China Life Insurance ADS (LFC), China Mobile Limited (CHL)
Those surprised by the market's strength in recent weeks should be even more impressed with the rebound in China, where both their market and economy have proven among the most resilient in the world.
Global specialist Nicholas Vardy adds, "While the US markets are rising, Asian stocks are on fire." ETF expert Paul Tracy adds, "China funds have screamed to the top of the performance charts."
In large part, this strength is due to the country's stimulus program. Tracy points out, "To combat the sagging global economy, Chinese Premier Wen Jiabao orchestrated a massive 4 trillion yuan ($586 billion) stimulus package.
Continue reading Investing in China: 12 experts pick their best bets
Posted Mar 28th 2009 3:30PM by Steven Halpern (RSS feed)
Filed under: International Markets, China, Newsletters, Stocks to Buy, Green Stocks
This post is part of a special report, Global advisors look to China.
"Bull markets are born in the pits of despair; from current low stock prices and low PE valuations, the gains over the coming 5 to 10 years could be truly spectacular," says Tom Bishop.
In his BI Research, the small cap growth specialist looks at two stocks that are based in China and set to benefit from China's stimulus program: energy efficiency play, SmartHeat (NASDAQ: HEAT) and medical diagnostics firm, Mindray Medical (NYSE: MR).
Continue reading Small cap expert eyes China favorites
Posted Jun 26th 2008 11:51AM by Eric Buscemi (RSS feed)
Filed under: Analyst Reports, Analyst Initiations
MOST NOTEWORTHY: Vale, Allos Therapeutics and Torchmark were today's noteworthy initiations:
- Lehman believes Vale (NYSE:RIO) is well-positioned to benefit from rising steel demand in emerging economies. The firm started shares with an Overweight rating and $45 target.
- Citigroup initiated Allos Therapeutics (NASDAQ:ALTH) with a Buy rating and $11 target and believes the company's lead drug PDX is likely to be the first FDA approved agent for peripheral T cell lymphoma.
- Friedman Billings expects Torchmark's (NYSE:TMK) sales to get back on track given increased recruiting, ongoing management initiatives, and the potential demise of Medicare Advantage. Shares were assumed with an Outperform rating and $72 target.
OTHER INITIATIONS:
Posted May 17th 2008 4:10PM by Trey Thoelcke (RSS feed)
Filed under: Earnings Reports, Home Depot (HD), Penney (J.C.) (JCP), Applied Materials (AMAT), Amer Intl Group (AIG), Lowe's Cos (LOW), Kohl's Corp (KSS), Toll Brothers (TOL), Deere and Co (DE), Barclays plc ADS (BCS), MBIA Inc (MBI)
Here are some highlights from this past week's earnings coverage from BloggingStocks:
Continue reading Earnings highlights: Deere, Freddie Mac, Applied Materials, Barclay's and others
Posted Aug 8th 2007 3:30PM by Tom Taulli (RSS feed)
Filed under: General Electric (GE)

It's been tough for healthcare IPOs. But in the case of the
debut of Masimo (NASDAQ: MASI) (ticker info unavailable at posting), things are certainly more upbeat. The stock is up about 19% in today's heavy trading.
Masimo develops non-invasive patient monitoring products to improve patient care. The systems involve circuit boards and reusable sensors as well as sophisticated software.
Because of the effectiveness of the technology, Masimo has had lots of traction with customers. For example, the company's worldwide installed base is about 399,000 units. Masimo also has major OEM agreements with companies like GE Medical Systems, a division of
General Electric Company (NYSE:
GE), Philips Medical Systems and
Mindray Medical International (NYSE:
MR).
Last year, Masimo posted revenues of $155.1 million. In fact, the compound annual growth rate (CAGR) has been 41.6% over the past four years. The company is also profitable
Lead underwriters of the deal included Piper Jaffray, Deutsche Bank Securities, and Citi.
The
prospectus is located at the SEC website. Also, if you want to see more recent IPO pricings, click
here.
Tom Taulli is the author of various books, including the Complete M&A Handbook and the EDGAR-Online Guide to Decoding Financial Statements.